Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07223541
What this trial is testing

Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
University of Oklahoma 72
Not applicableStudy completedNCT02228954
What this trial is testing

IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)

Who this might be right for
Clear-cell Metastatic Renal Cell CarcinomaKidney Neoplasms
Radboud University Medical Center 40
Not applicableUnknownNCT03694912
What this trial is testing

Development and Evaluation of High Risk Group Prediction Model in T1 Stage Renal Cell Cancer Using Molecular Biomarkers

Who this might be right for
Clear Renal Cell Cancer (< 7cm Size)
Yonsei University 426
Not applicableStudy completedNCT06883565
What this trial is testing

Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study

Who this might be right for
Renal Cell Carcinoma (RCC)
Ding-Wei Ye 232
Not applicableStudy completedNCT02687139
What this trial is testing

Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Johns Hopkins University 34
Testing effectiveness (Phase 2)Study completedNCT00282048
What this trial is testing

Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer

Who this might be right for
Kidney NeoplasmsCarcinoma, Renal Cell
Pfizer 62
Early research (Phase 1)Study completedNCT04991740
What this trial is testing

JNJ-78306358 in Participants With Advanced Stage Solid Tumors

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 39
Early research (Phase 1)Study completedNCT01548482
What this trial is testing

Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Adult Solid NeoplasmLung Carcinoid TumorRecurrent Digestive System Neuroendocrine Tumor G1+8 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT00462982
What this trial is testing

Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer
Memorial Sloan Kettering Cancer Center 8
Not applicableStudy completedNCT04570176
What this trial is testing

Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System

Who this might be right for
Renal Cell CarcinomaBladder CancerAdrenal Tumor
The Affiliated Hospital of Qingdao University 1
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Large-scale testing (Phase 3)Study completedNCT02231749
What this trial is testing

Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

Who this might be right for
Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Bristol-Myers Squibb 1,096
Testing effectiveness (Phase 2)Active Not RecruitingNCT06708949
What this trial is testing

Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma, Clear Cell
M.D. Anderson Cancer Center 52
Not applicableStudy completedNCT05042089
What this trial is testing

Predictive Imaging Features in Renal Cell Carcinoma

Who this might be right for
Renal Malignant Tumor
Ankara Yildirim Beyazıt University 92
Early research (Phase 1)Looking for participantsNCT06321250
What this trial is testing

JMKX003948 Tablets in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma Metastatic
Jemincare 80
Not applicableStudy completedNCT00718367
What this trial is testing

Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens

Who this might be right for
Renal Cell Carcinoma
National University Hospital, Singapore
Testing effectiveness (Phase 2)Ended earlyNCT00098618
What this trial is testing

Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaPapillary Renal Cell CarcinomaRecurrent Renal Cell Cancer+2 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT02431676
What this trial is testing

Survivorship Promotion In Reducing IGF-1 Trial

Who this might be right for
Breast CancerProstate CancerLung Cancer+8 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 121
Not applicableUnknownNCT00980317
What this trial is testing

A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties

Who this might be right for
Kidney NeoplasmsRenal InsufficiencyRenal Replacement Therapy
Tokushukai Medical Group 5
Testing effectiveness (Phase 2)Study completedNCT00003390
What this trial is testing

6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Next Page